Harvard Business Review
JUNE 16, 2016
The initial breakthrough came in 1987, but the first drug wasn’t approved until 2011. In 2011, he commissioned a report that called for an “innovation policy” rather than an “industrial policy.” So far, the program has exceeded the expectations of the initial plan. The Era of Big Science.
Harvard Business Review
SEPTEMBER 14, 2011
In 2008, Dr Reddy's acquired Chirotech, Dow Chemical's R&D unit, for $32 million, and in April 2011 relocated it to a new 33,000 sq. Dr Reddy's plan is to leverage Chirotech's scientific capabilities to optimize drug development processes, thus lowering manufacturing costs and speeding time-to-market.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Harvard Business Review
FEBRUARY 19, 2015
Your timeline, she says, should include clearly defined savings targets for each month or quarter and — if necessary — a plan for raising money from investors. “But if you’ve planned your transition well, you’re not taking a heedless risk.” ” Further Reading. ” Principles to Remember.
Harvard Business Review
MARCH 5, 2012
Health care , which receives a huge tax break (employer-sponsored health care plans are paid for with pre-tax dollars). And one look at the trade deficit ($558 billion in 2011) clearly indicates we don't have as much as our foreign competitors to sell in return. To make up the difference, we just borrow. The Right Policies.
Harvard Business Review
SEPTEMBER 11, 2014
For example, a wide variety of clean technologies (including wind, solar, and hydrogen) are vying to power vehicles and cities at the same time that a wide variety of medical technologies (chemical, biotechnological, genomic, and robotic) are being developed to treat diseases. Consider the 2×2 matrix below.
Expert insights. Personalized for you.
8 
Let's personalize your content